Amit Mishra1, Mehul Shah2, Pranav Sharma3, Jignesh Kothari3, Amber Malhotra2. 1. Associate Professor, Pediatric Cardiac Surgery, Department of Cardiovascular and Thoracic Surgery, U.N. Mehta Institute of Cardiology and Research Center, Asarwa, Ahmedabad 380016, Gujarat, India. 2. Associate Professor, Department of Cardiovascular and Thoracic Surgery, U.N. Mehta Institute of Cardiology and Research Center, Ahmedabad, Gujarat, India. 3. Assistant Professor, Department of Cardiovascular and Thoracic Surgery, U.N. Mehta Institute of Cardiology and Research Center, Ahmedabad, Gujarat, India.
Abstract
BACKGROUND: Cardiac myxomas are the most common benign intracardiac tumors. We studied the clinical presentation of cardiac myxomas, their morbidity, mortality and recurrence rate following surgery at our institution over a period of four years. METHODS: During August 2008 to November 2012, a total of 12023 cardiac surgeries were performed. Amongst these, 50 patients (12 males, 38 females) underwent complete removal of primary or recurrent intracardiac myxomas. Complete tumor excision with a cuff of interatrial septum followed copious saline irrigation of the cardiac chambers was performed in each case. RESULTS: Forty six patients survived the surgery of which 43 are being followed up at regular intervals for development of recurrence. Myxomas constituted 0.41% of the total cardiac surgeries at our institute. Most of them were noted in the fourth decade. The commonest location was left atrium (74%) followed by right atrium (22%). Only one patient had a myxoma in the right ventricle. Forty six patients (92%) survived the surgery. CONCLUSION: Cardiac myxoma excision account for a very small percentage of cardiac procedures. Immediate surgical treatment is indicated in all patients. Cardiac myxomas can be excised with a low rate of mortality and morbidity.
BACKGROUND:Cardiac myxomas are the most common benign intracardiac tumors. We studied the clinical presentation of cardiac myxomas, their morbidity, mortality and recurrence rate following surgery at our institution over a period of four years. METHODS: During August 2008 to November 2012, a total of 12023 cardiac surgeries were performed. Amongst these, 50 patients (12 males, 38 females) underwent complete removal of primary or recurrent intracardiac myxomas. Complete tumor excision with a cuff of interatrial septum followed copious saline irrigation of the cardiac chambers was performed in each case. RESULTS: Forty six patients survived the surgery of which 43 are being followed up at regular intervals for development of recurrence. Myxomas constituted 0.41% of the total cardiac surgeries at our institute. Most of them were noted in the fourth decade. The commonest location was left atrium (74%) followed by right atrium (22%). Only one patient had a myxoma in the right ventricle. Forty six patients (92%) survived the surgery. CONCLUSION:Cardiac myxoma excision account for a very small percentage of cardiac procedures. Immediate surgical treatment is indicated in all patients. Cardiac myxomas can be excised with a low rate of mortality and morbidity.
Authors: P Centofanti; E Di Rosa; L Deorsola; G M Dato; F Patanè; M La Torre; L Barbato; A Verzini; G Fortunato; M di Summa Journal: Ann Thorac Surg Date: 1999-10 Impact factor: 4.330
Authors: E Castells; V Ferran; M C Octavio de Toledo; J M Calbet; M Benito; C Fontanillas; J Granados; C L Obi; E Saura Journal: J Cardiovasc Surg (Torino) Date: 1993-02 Impact factor: 1.888
Authors: J R Dein; W H Frist; E B Stinson; D C Miller; J C Baldwin; P E Oyer; S Jamieson; R S Mitchell; N E Shumway Journal: J Thorac Cardiovasc Surg Date: 1987-04 Impact factor: 5.209
Authors: P M McCarthy; J M Piehler; H V Schaff; J R Pluth; T A Orszulak; H J Vidaillet; J A Carney Journal: J Thorac Cardiovasc Surg Date: 1986-03 Impact factor: 5.209